Phase 2 trial shows daridorexant boosts pediatric insomnia sleep time up to 50 minutes, including ADHD/ASD patients, with strong safety and phase 3 plans.
|Videos|January 25, 2021
Coronasomnia
Author(s)Thomas So, PharmD
The stress and anxiety of the COVID-19 pandemic might be interfering with sleep patterns.
Advertisement
Thomas So, PharmD, discusses getting a better night's sleep, even during the pandemic.
Dr So is Manager at the Meducation Group at First Databank (FDB).
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Schizo-Obsessed! Untangling the Overlap Between Obsessive Compulsive Disorder and Schizophrenia
2
Can Digital Memory Tests Detect Tau-Related Cognitive Change Before Alzheimer Disease?
3
FDA Shelves Fast-Track Drug Review Initiative
4
New National Guidance for Managing Medetomidine Intoxication and Withdrawal
5